Relating to labeling requirements for compounded drug products.

HB 3785 requires pharmacies and manufacturers to label compounded drug products with specific information, directly affecting patients, pharmacists, and healthcare providers. The bill mandates labels include the patient's name, pharmacy details, a "Compounded Drug" statement, all active ingredients, expiration date, quantity, storage instructions, usage directions, side effects, facility type (sterile/non-sterile), and preparation location. These labeling standards apply to drugs distributed via telepharmacy, over-the-counter sales, or direct patient dispensing. The Texas State Board of Pharmacy must adopt implementing rules by December 1, 2025, with the law taking effect September 1, 2025.